A Phase 1B/2 study to evaluate safety and anti-tumour activity of AVELUMAB in combination with POLY (ADENOSINE DIPHOSPHATE [ADP]-RIBOSE) POLYMERASE (PARP) inhibitor TALAZOPARIB in patients with locally advance or metastatic solid tumours

  • Sabanathan, Dhanusha (Primary Chief Investigator)
  • Kefford, Richard (Chief Investigator)
  • Butala, Radhika (Research Coordinator)
  • Cunningham, Jacob (Other)

Project: Research

Project Details

Short titleB9991025
Effective start/end date19/07/185/01/21